Structural attributes of leishmanial phosphoenolpyruvate carboxykinase and identification of its novel inhibitors

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Journal of Molecular Structure

• Publication date

  2026-02-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.molstruc.2025.144724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines.

  2025cited by this paper
• Exploration of membrane-bound ecto-phosphatase to identify potential therapeutic target for leishmaniasis.

  2025cited by this paper
• Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases

  2024cited by this paper
• Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes.

  2024cited by this paper
• Protein Kinases - High Yield Targets for Cancer and Dementia Drug Discovery: Protein kinase treatment targets.

  2024cited by this paper
• Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer.

  2024cited by this paper
• Inhibition and structural insights of leishmanial glutamyl-tRNA synthetase for designing potent therapeutics.

  2023cited by this paper
• Exploration of seryl tRNA synthetase to identify potent inhibitors against leishmanial parasites.

  2023cited by this paper
• Protein kinases: drug targets for immunological disorders

  2023cited by this paper
• Design, Synthesis, and Biological Evaluation of Sulfonamide Methoxypyridine Derivatives as Novel PI3K/mTOR Dual Inhibitors

  2023cited by this paper
• The Phosphoenolpyruvate Carboxykinase Is a Key Metabolic Enzyme and Critical Virulence Factor of Leishmania major

  2021cited by this paper
• Leishmania Protein Kinases: Important Regulators of the Parasite Life Cycle and Molecular Targets for Treating Leishmaniasis

  2021cited by this paper
• Biochemical and structural insights into 6-phosphogluconate dehydrogenase from Leishmania donovani

  2021cited by this paper
• Biophysical and Structural Characterization of Ribulose-5-phosphate Epimerase from Leishmania donovani

  2021cited by this paper
• Systematic functional analysis of Leishmania protein kinases identifies regulators of differentiation or survival

  2020cited by this paper
• Kinetic and structural analysis of Escherichia coli phosphoenolpyruvate carboxykinase mutants.

  2020cited by this paper
• Structural attributes and substrate specificity of pyridoxal kinase from Leishmania donovani.

  2020cited by this paper
• Leishmanial aspartyl-tRNA synthetase: Biochemical, biophysical and structural insights.

  2020cited by this paper
• Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An in silico study

  2020cited by this paper
• Structural comparisons of phosphoenolpyruvate carboxykinases reveal the evolutionary trajectories of these phosphodiester energy conversion enzymes

  2019cited by this paper
• Protein phosphatase 1 of Leishmania donovani exhibits conserved catalytic residues and pro-inflammatory response.

  2019cited by this paper
• Sulfonamide derivatives as multi-target agents for complex diseases.

  2019cited by this paper
• Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development

  2019cited by this paper
• Recent Developments and Applications of the MMPBSA Method

  2018cited by this paper
• Structural Control of Nonnative Ligand Binding in Engineered Mutants of Phosphoenolpyruvate Carboxykinase.

  2018cited by this paper
• Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme

  2017cited by this paper
• The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)

  2017cited by this paper
• Exploring biochemical and functional features of Leishmania major phosphoenolpyruvate carboxykinase.

  2015cited by this paper
• Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells

  2015cited by this paper
• Probing the Metabolic Network in Bloodstream-Form Trypanosoma brucei Using Untargeted Metabolomics with Stable Isotope Labelled Glucose

  2015cited by this paper
• GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers

  2015cited by this paper
• g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations

  2014cited by this paper
• Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.

  2014cited by this paper
• Phosphoproteomic analysis of differentiating Leishmania parasites reveals a unique stage-specific phosphorylation motif.

  2013cited by this paper
• Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

  2012cited by this paper
• Recent advances in medicinal chemistry of sulfonamides. Rational design as anti-tumoral, anti-bacterial and anti-inflammatory agents.

  2012cited by this paper
• Regulation of glycolysis and gluconeogenesis by acetylation of PKM and PEPCK.

  2011cited by this paper
• Crystal Structures of Two Aminoglycoside Kinases Bound with a Eukaryotic Protein Kinase Inhibitor

  2011cited by this paper
• Isotopomer Profiling of Leishmania mexicana Promastigotes Reveals Important Roles for Succinate Fermentation and Aspartate Uptake in Tricarboxylic Acid Cycle (TCA) Anaplerosis, Glutamate Synthesis, and Growth*

  2011cited by this paper
• Definition and testing of the GROMOS force-field versions 54A7 and 54B7

  2011cited by this paper
• Interaction study of pioglitazone with albumin by fluorescence spectroscopy and molecular docking.

  2011cited by this paper
• Virtual screening in drug design and development.

  2010cited by this paper
• Crystal structure and trimer-monomer transition of N-terminal domain of EhCaBP1 from Entamoeba histolytica.

  2010cited by this paper
• Drug Resistance in Visceral Leishmaniasis

  2009cited by this paper
• Structural Insights into the Mechanism of Phosphoenolpyruvate Carboxykinase Catalysis*

  2009cited by this paper
• Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase.

  2006cited by this paper
• Crystal structure of Anaerobiospirillum succiniciproducens PEP carboxykinase reveals an important active site loop.

  2005cited by this paper
• Structure of ATP-dependent phosphoenolpyruvate carboxykinase from Thermus thermophilus HB8 showing the structural basis of induced fit and thermostability.

  2005cited by this paper
• Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi

  2005cited by this paper
• New insights into the developmental biology and transmission mechanisms of Leishmania.

  2004cited by this paper
• Structure/function studies of phosphoryl transfer by phosphoenolpyruvate carboxykinase.

  2004cited by this paper
• Mechanisms of Activation of Phosphoenolpyruvate Carboxykinase from Escherichia coli by Ca2+ and of Desensitization by Trypsin

  2003cited by this paper
• Crystal structure of human cytosolic phosphoenolpyruvate carboxykinase reveals a new GTP-binding site.

  2002cited by this paper
• Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution.

  2001cited by this paper
• How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment

  2001cited by this paper
• Structure and Mechanism of Phosphoenolpyruvate Carboxykinase*

  1997cited by this paper
• Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors.

  1996cited by this paper
• Crystal structure of Escherichia coli phosphoenolpyruvate carboxykinase: a new structural family with the P-loop nucleoside triphosphate hydrolase fold.

  1996cited by this paper
• Phosphoenolpyruvate carboxykinase from Trypanosoma cruzi. Purification and physicochemical and kinetic properties.

  1995cited by this paper
• Molecular and expression analysis of the Rhizobium meliloti phosphoenolpyruvate carboxykinase (pckA) gene

  1995cited by this paper
• Intermediary metabolism of Trypanosoma cruzi.

  1994cited by this paper
• Intermediate metabolism inTrypanosoma cruzi

  1994cited by this paper
• Inhibition of phosphoenolpyruvate carboxykinase from Trypanosoma (Schizotrypanum) cruzi epimastigotes by 3-mercaptopicolinic acid: in vitro and in vivo studies.

  1990cited by this paper
• The FASEB Journal • Research Communication Retooling Leishmania metabolism: from sand fly gut to human macrophage

  year unknowncited by this paper

• No citing papers are available for this paper.